06/01/2026
Starting July 1, many people in Medicare will have a new option to help access GLP-1 obesity medications. Under the new Medicare GLP-1 Bridge program monthly medication copays would be capped at a flat $50.
Medicare coverage can be confusing, especially when it comes to obesity treatment. This program is designed to help make care more affordable and easy to access.
Not everyone will qualify, but if you are on Medicare - or about to be - and have been waiting for more affordable obesity treatment options, now is a good time to talk with your healthcare provider. Learn more: https://bit.ly/49X5lC0